PubMed Health⌕ Search

Biomedical subjects

M Coltorti

Publications and source records attributed to M Coltorti.

At least 55 records · Page 3Linked to original sources
PubMed1983

Membranous glomerulopathy and hepatitis B virus (HBV) infection in children.

Histological examination of renal biopsies in 64 Neapolitan children aged 13 months to 14 years who presented with nephrotic syndrome or persistent hematuria and/or proteinuria revealed membranous glomerulopathy (M.G.) in 14. Hepatitis B surface antigen (HBsAg) was found in the serum of 9/14 children with M.G. and in 1/14 children in an age and sex matched control group. The prevalence of HBsAg positivity in the M.G. children suggests a relationship between HBV infection and the disease. The high prevalence of males in HBsAg positive M.G. children suggests that males have an increased risk of contracting M.G. The absence of chronic liver disease in 8/9 HBsAg positive M.G. patients, and the lack of correlation between the clinical manifestations of kidney disease and the rate of HBV replication indicate that different mechanisms underlie the hepatic and renal pathologies.

Adolescent↗
PubMed1979

[Gastrin stimulation of salivary secretion: preliminary observations].

The authors have investigated the effect of pentagastrin and of meat extract on salivary secretion. Both stimuli significantly increase the secretion of saliva. Factors such as taste and deglutition don't influence the increase of salivary secretion due to meat extract, as it remains even when meat extract was administered by naso-gastric tube. This finding suggest that endogenous gastrin, stimulated by meat extract, as well as exogenous pentagastrin, influence the secretion of saliva.

Adult↗
PubMed1979

[Mechanisms of detecting organic cholephilic anions in man: comparative studies on plasma depuration of rifamycin-SV. Interference of nicotinic acid and phenobarbital].

We have studied plasmatic half-life of R-SV administered alone and in association with nicotinic acid, before and after treatment with phenobarbital, in 10 normobilirubinaemic subjects and in 10 patients Gilbert's syndrome, used like controls. Ouer results confirm the existence of some alterations of drug-metabolism produced by associated administration of other drugs, in both healthy and hyperbilirubinaemic subjects, and in these one even more.

Adolescent↗
PubMed1979

[Influence of allopurinol on the half-life of tolbutamide and rifamycin-SV in blood of healthy volunteers].

The influence of treatment with allopurinol (5 mg/kg/die for 15 days) on T/2 of tolbutamide and rifomycin-SV intravenously administered, has been studied in 10 healthy volunteers. We have observed reduction of T/2 of tolbutamide and, on the contrary, prolongation of T/2 of rifamycin-SV. Tolbutamide behaviour was unexpected, considering that other Authors had previously found inhibition of metabolic degradation of other drugs metabolized by the microsomal enzymes. We conclude that data concerning the influence of a drug (in our case, allopurinol) on the metabolism of another drug cannot always authorize general deduction and previsions regarding the metabolic interferences on the pharmacokinetics of other substances.

Adult↗
PubMed1975

[Geographical differences in the incidence of Australia antigen in chronic liver diseases].

In order to evaluate the role of the Australia Antigen and of the many other factors commonly invoked in the etiology of chronic liver diseases a series of study have been performed by radioimmunoassay on: a group of blood donors who showed persistent antigenemia and two groups of patients with chronic hepatitis who were studied respectively at Brescia General Hospital and at the Departement of Internal Medicine of the University of Naples. The results were as it follows: 1) Liver damage, from mild to severe (from transient increase of GOT and GPT levels to cirrhosis) was present in 69 out of 145 blood donors with persistent antigenemia. 2) Antigenemia was more frequent in the neapolitan group of patients not only when considering the entire study population (39%) but also when the cirrhotic group was considered (40.7%). In the Brescia study group the figures were 11.7% and 8.6% respectively. 3) Comparable high incidence of antigenemia was present in both groups when only patients with chronic aggressive hepatitis and liver carcinoma were considered. 4) When only patients with chronic persistent hepatitis and chronic aggressive hepatitis were considered the incidence of antigenemia was remarkably different.

Antibody Formation↗
PubMed1974

[Influence of cholestasis on enzymatic induction with phenobarbital and other enzymatic aspects: experimental studies on guinea pigs].

Investigations in guinea pigs to evaluate interferences between cholestasis and enzymatic induction by phenobarbital, and influences that both experimental conditions exert on the levels of gamma-glutamyl transpeptidase in microsomes and other subcellular fractions, have shown that: 1) cholestasis inhibits inductions of cytochrome P-450 from phenobarbital; 2) gamma-glutamyl transpeptidase is not an inducible enzyme in guinea pig; 3) rises or ferum gamma-glutanyl transpeptidase produced either by cholestasis or phenobarbital administration, are not related to an increased enzymatic synthesis in the various subcellular fractions of liver cell.

Animals↗